Research Article

ETM-ANN Approach Application for Thiobenzamide and Quinolizidine Derivatives

Table 1

A list of chemical molecules under investigation.

NoXR1R2R3R4R5Activity,
EC50 ( 𝜇 g/mL)

Skeleton I

1OOHClHHH0.06
2SHClHHHNA
3SHHHHHNA
4SMeHHHHNA
5SHMeHHHNA
6SHFHHHNA
7SHCF3HHHNA
8SHHMeHHNA
9SMeHMeHHNA
10SMeHHMeHNA
11SHMeHMeHNA
12SOMeHHHHNA
13OOHHHHH0.05
14SOHHHHH4.5
15OOHHHMeH0.03
16SOHHHMeH0.4
17SOHHHClH0.9

Skeleton II

18OOHHHClH0.2
19SHClHHH0.02
20SHHHHH0.05
21SMeHHHH 0 . 0 6 5 ± 0 . 0 3 5
22SHMeHHH 0 . 0 1 5 ± 0 . 0 0 7
23SHFHHH0.038
24SHCF3HHH0.09
25SHHMeHHNA
26SMeHMeHH0.15
27SMeHHMeH 0 . 0 2 3 ± 0 . 0 1 1
28SHMeHMeH 0 . 0 3 ± 0 . 0 7
29SOMeHHHH1.0
30OOHHHHH25
31SOHHHHH2
32OOHHHMeH 0 . 1 5 ± 0 . 0 7 1
33SOHHHMeH0.5
34SOHHHClH1.8
35SHCNHHH2.5
36SHNO2HHHNA
37SHCO2MeHHHNA

Skeleton III

38OOHHNH2ClH1–3
39OOMeHNH2ClHNA
40OHHNH2ClHNA
41OOHHHHH1.6–3.1
42OOHHNH2HHNA
43OOHHHFH0.4–0.8
44OOHHHClH0.8
45OOHHHBrH0.8
46OOHHHMeH0.2-0.3
47OOHHHOMeH0.6
Skeleton III

48OOHHHOHHNA
49OOHHHCF3HNA
50OOHHHCH=CH2H2
51OOHHHN3H0.5
52OOHHHtert-BuHNA
53OOHHHPhHNA
54OOHHHPhCOHNA
55OOHHCH3HH4
56OOHHN3ClHNA
57OOHH–CH=CH–CH=CH–HNA
58OOHHH–CH=CH–CH=CH–NA
59OOHH–(Me)2–CCH2CH2C–(Me)2HNA
60OOHCH3HHH8
61OOHClHClH10–20
62OOHOHHHHNA
63OOHHHHF10
64ONH2HHHH5–10
65OCH3CONHHHHHNA

NA, not active.